Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Director/PDMR Shareholding

4 Apr 2012 11:57

Interserve Plc Notification of Transactions of Directors/ Persons Discharging Managerial Responsibility and Connected Persons

Pursuant to Disclosure and Transparency Rule 3.1.2, Interserve Plc (the "Company") announces that it was informed on 3 April 2012 by EES Trustees International Limited, in its capacity as Trustee of the Interserve Employee Benefit Trust, that the following ordinary shares of 10p each in the Company were transferred for no consideration to certain Executive Directors/Person Discharging Managerial Responsibilities ("PDMR") on 23 March 2012 pursuant to the Interserve Plc Performance Share Plan 2006. The number of shares vested was subject to the satisfaction of certain performance conditions over a three-year period based on earnings per share and total shareholder return.

Executive Directors

1. 61,576 shares acquired by Mr Steven Dance (0.049% of issued share capital). 27,005 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Dance now has an interest in 99,534 ordinary shares of 10p each in the Company (0.079%% of issued share capital).

2. 61,576 shares acquired by Mr Bruce Melizan (0.049% of issued share capital). 27,005 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Melizan now has an interest in 100,521 ordinary shares of 10p each in the Company (0.079% of issued share capital).

3. 51,724 shares acquired by Mr David Paterson (0.041% of issued share capital). 22,684 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Paterson now has an interest in 46,975 ordinary shares of 10p each in the Company (0.037% of issued share capital).

4. 103,448 shares acquired by Mr Adrian Ringrose (0.082% of issued share capital). 45,368 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Ringrose now has an interest in 263,060 ordinary shares of 10p each in the Company (0.208% of issued share capital).

5. 45,300 shares acquired by Mr Douglas Sutherland (0.036% of issued share capital). 19,867 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Sutherland now has an interest in 51,408 ordinary shares of 10p each in the Company (0.041% of issued share capital).

PDMR

1. 37,006 shares acquired by Mr Trevor Bradbury (0.029% of issued share capital). 16,230 shares were disposed of at an average share price of £2.974816 per share on the London Stock Exchange over a period between 26-30 March 2012 to pay for tax/NI and sale costs. The remaining shares have been retained. Mr Bradbury now has an interest in 62,287 ordinary shares of 10p each in the Company (0.049% of issued share capital).

4 April 2012Trevor BradburyGroup SecretaryTel: 0118 932 0123

PINX
Date   Source Headline
18th Oct 20179:25 amRNSHolding(s) in Company
16th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 20177:30 amRNSStatement following recent media coverage
12th Oct 20173:46 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSInterserve wins Leeds housing development contract
6th Oct 20179:08 amRNSHolding(s) in Company
5th Oct 20178:50 amRNSHolding(s) in Company
3rd Oct 20172:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSInterserve-led consortium chosen for £85m project
2nd Oct 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Sep 201711:33 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSInterserve wins place on £8bn CMA framework
26th Sep 201710:49 amRNSHolding(s) in Company
26th Sep 201710:42 amRNSHolding(s) in Company
20th Sep 20179:03 amRNSHolding(s) in Company
19th Sep 20174:26 pmRNSHolding(s) in Company
19th Sep 20179:45 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSHolding(s) in Company
18th Sep 20172:09 pmRNSDirector/PDMR Shareholding
18th Sep 20171:48 pmRNSHolding(s) in Company
18th Sep 201712:00 pmRNSDirector/PDMR Shareholding
18th Sep 201710:08 amRNSHolding(s) in Company
18th Sep 201710:04 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSMark Whiteling appointed Chief Financial Officer
15th Sep 20173:33 pmRNSHolding(s) in Company
15th Sep 20172:16 pmRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSTrading Update
13th Sep 20179:18 amRNSDirector/PDMR Shareholding
12th Sep 201711:44 amRNSDirector/PDMR Shareholding
12th Sep 201710:16 amRNSHolding(s) in Company
11th Sep 201711:13 amRNSHolding(s) in Company
6th Sep 20179:24 amRNSHolding(s) in Company
6th Sep 20177:00 amRNSInterserve wins £90m DfT FM contract
1st Sep 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Aug 201711:42 amRNSHolding(s) in Company
24th Aug 20174:27 pmRNSHolding(s) in Company
24th Aug 201710:42 amRNSHolding(s) in Company
24th Aug 20179:18 amRNSPublication of Half-Year Report
24th Aug 20178:46 amRNSHolding(s) in Company
17th Aug 20179:33 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSInterserve and Amec Foster Wheeler Joint Venture
14th Aug 20172:17 pmRNSHolding(s) in Company
14th Aug 20172:16 pmRNSHolding(s) in Company
9th Aug 20173:01 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSHalf-Year Results 2017
13th Jul 20174:25 pmRNSDirector/PDMR Shareholding
12th Jul 201712:52 pmRNSDirector/PDMR Shareholding
12th Jul 20179:44 amRNSHolding(s) in Company
3rd Jul 20177:00 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.